In New Study, Duloxetine Reduced Non-specific Pain and Emotional,Symptoms Associated with Depression ( derectile dysfunction. Duloxetine is...)

In New Study, Duloxetine Reduced Non-specific Pain and Emotional,Symptoms Associated with Depression

d erectile dysfunction.

Duloxetine is contraindicated in patients who are allergic to it, who have liver disease resulting in hepatic impairment, who are taking a monoamine oxidase inhibitor (MAOI), fluvoxamine, ciprofloxacin or enoxacine or who have severe kidney disease. The initiation of treatment with duloxetine also is contraindicated in patients with uncontrolled hypertension that could expose patients to a potential risk of hypertensive crisis.

About Depression
Major Depressive Disorder (MDD) affects approximately 121 million people worldwide.1 The World Health Organization estimates depression will be among the highest-ranking causes of disability in developed countries by 2020, second only to ischemic heart disease worldwide.2 It can happen to anyone of any age, race or ethnicity; however, women are nearly twice as likely to experience depression as men.3 Although it is one of the most frequently seen psychiatric disorders in the primary care setting, it often goes undiagnosed or is under-treated.4 This may be because depressed people often present physical symptoms rather than emotional complaints; pain is present in approximately 45 to 95 percent of patients with MDD, and can include headache, back, shoulder and abdominal pain.5

Complete elimination of symptoms, or remission, is the primary goal of depression treatment. Treating the full spectrum of emotional and physical symptoms to remission decreases a patient’s risk of relapse.6

Eli Lilly and Company and Boehringer Ingelheim
In November 2002, Eli Lilly and Company and Boehringer Ingelheim signed a long-term agreement to jointly develop and commercialize duloxetine hydrochloride. This partnership covers neuroscience indications in most countries outside of the United States and Japan, with few exceptions.

About Eli Lilly and Company
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of best-in-class pharmaceutical
'"/>

Page: 1 2 3 4 5 6
Related medicine technology :

1. In New Study, Duloxetine Was Equally Effective, Regardless of Switch Method, in Reducing Painful Symptoms in Ssri Non- or Partial-responders with Depression
2. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
3. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
4. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
5. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
6. Lipitor Reduced the Risk of Coronary Events by Half and Stroke by Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who Experienced a Recent Stroke
7. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
8. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
9. New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
10. Pivotal Phase III Trial Showed Promacta (eltrombopag olamine) Raised Platelet Counts and Reduced Bleeding in Patients With Chronic ITP
11. Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have Reduced Potential to Develop Resistance to Panacos Bevirimat

Post Your Comments:

(Date:12/16/2009)... 16 According to Millennium Research Group ... intelligence, although the US minimally invasive spinal fusion ... rate of over 12% through 2014, reimbursement concerns ... overall market, which previously had been forecast at ... Minimally Invasive Spine Technologies 2010 ...

(Date:12/16/2009)... Medlytix, a national healthcare consulting firm, reported success ... milestone - the total amount of money that ... to more than a half-million patients nationwide by ... care - in less than two years. ,, ... their bottom lines and still were able to ...

(Date:12/16/2009)... SOLON, Ohio, Dec. 16 HDT Engineered ... next generation technologies and a principal subcontractor for ... (MPL), led development of new anthropromorphic arm technology ... a prosthetic arm and hand, including a sense ... Defense Advanced Research Projects Agency (DARPA) Revolutionizing Prosthetics ...

[0] Reimbursement Difficulties With TranS1's AxiaLIF and NuVasive's XLIF Have Sceptics Talking [0] Healthcare Scoring System Allows Hospitals To Increase Charity Care [0] HDT Develops Robotic Arm Technology for DARPA's Revolutionizing Prosthetics 2009 Program

... - ZIOPHARM Oncology, Inc.,(NASDAQ: ZIOP) announced today that ... the C.E. Unterberg, Towbin,Emerging Growth Opportunities Conference on ... the Mandarin Oriental Hotel, New York. Dr. Lewis,will ... update on its,clinical development programs., The presentation will ...

... -- Micromet,Inc. , a biopharmaceutical company focusing on ... inflammatory,and autoimmune diseases, today announced that Dr. Christian ... will,present at the 3rd Annual C.E. Unterberg, Towbin ... 12, 2007 at 10:00am,eastern. , A webcast of ...

Other Medicine Technology:ZIOPHARM to Present at C.E. Unterberg, Towbin Emerging Growth,Opportunities Conference 2 Micromet, Inc. to Present at the 3rd Annual C.E. Unterberg, Towbin,Emerging Growth Conference 2

ZIOPHARM to Present at C.E. Unterberg, Towbin Emerging Growth,Opportunities Conference Micromet, Inc. to Present at the 3rd Annual C.E. Unterberg, Towbin,Emerging Growth Conference

(Date:12/16/2009)... NORCROSS, Ga., Dec. 16 Immucor, Inc. (Nasdaq: ... instrument-reagent systems to the blood transfusion industry, today announced ... its board as a new independent director, effective January ... in blood banking and transfusion medicine for more than ... and Medicine at the University of Virginia School of ...

(Date:12/16/2009)... Dec. 16 Losing has never felt so ... maintaining his healthy new lifestyle means continuing to make ... fat free milk is one healthy choice that is ... simple step everyone can take. Every glass of milk ... potassium to help maintain normal blood pressure, and calcium ...

(Date:12/16/2009)... Allscripts (Nasdaq: MDRX ) announced today that ... three and six months ended November 30, 2009 ... 11, 2010. Allscripts management will host a conference ... and other information at 8:30 AM Eastern Standard ... http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO ) ,, Allscripts fiscal second quarter earnings ...

(Date:12/16/2009)... LAUREL, Md., Dec. 16 For ... Army Medical Center in Washington, D.C., the holidays can ... aren,t able to travel home rely more than ever ... friends. This week, calling home just got easier ... in free calling cards, which will provide hundreds of ...

(Date:12/16/2009)... 16 The most widely used human embryonic stem ... social justice questions that must be addressed to ensure ... advances, according to a University of Michigan research team. ... the U-M team analyzed 47 embryonic stem cell lines, ... cell researchers. The scientists determined the genetic ancestry of ...

Breaking Medicine News(10 mins):Health News:Immucor Appoints New Board Director 2 Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 2 Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 3 Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 4 Health News:Verizon Wireless Donates $10,000 in Long-Distance Calling Cards to Soldiers at Walter Reed Hospital 2 Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 2 Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 3 Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 4 Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 5

[0] Immucor Appoints New Board Director [0] 'The Biggest Loser' Champ Lives Well With Milk [0] Allscripts to Announce Second Quarter Fiscal 2010 Results [0] Verizon Wireless Donates $10,000 in Long-Distance Calling Cards to Soldiers at Walter Reed Hospital [0] U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines

... Ohio Research here shows that an obscure form of ... play an important role in human cancer. , These ... researchers, but a new report in the September issue of ... the case. , The study found that UCRs, like ...

... has rescue workers, medical experts frustrated , , TUESDAY, Sept. ... of the Sept. 11, 2001, World Trade Center disaster ... , First, workers inhaled a toxic cocktail of soot, ... 12-hour shifts that lasted for weeks. There was also ...

... Executive Vice President, Corporate Development and, ... PRINCETON, N.J., Sept. 11 Pharmacopeia,(Nasdaq: ... development of novel,small molecule therapeutics, today announced the ... Corporate Development and S. David,Kimball, Ph.D., as Senior ...

... Vista Partners announced today,that it has updated coverage ... Director of Research for Vista Partners stated, "Tapestry,s,lead ... We were,particularly encouraged by activity in patients with ... for use in this difficult to treat,cancer." Vista ...

... China,Bionanometer Industries Corporation (OTC Pink Sheets: CBIU), a ... a new,series of biological nanometer cosmetics products named ... and experiments. The,name comes from the Italian word ... means -- "One,s Dreams Coming True." The ...

... PORT WASHINGTON, N.Y., Sept. 10 National,Medical Health Card ... benefit manager ("PBM"), today reported its results for the ... Three months ended June 30, 2007 Revenue ... as,compared to revenue of $211.5 million for the same ...

New class of RNA molecules may be important in human cancer 6 Years Later, 9/11 Health Questions Linger Pharmacopeia Announces Senior Additions to Management Team Vista Partners Updates Coverage on Tapestry Pharmaceuticals China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results

Histopathology Reference Laboratory provides a full range of histology services, encompassing routine and specialized grossing, processing, embedding, microtomy, routine and special staining and cove...

PhenoPath Laboratories provides screening, diagnostic, and prognostic testing services to hospitals, physician offices, surgery centers, biopharmaceutical companies and research institutions nationwi...

Headquartered in Burlington, North Carolina, LabCorp has more than 23,500 employees and offers more than 4,400 clinical tests ranging from routine blood analyses to the most sophisticated molecular d...

... The Johns Hopkins University Dermatology, ... Laboratory is a federally-(Clinical Laboratory Improvement ... that began operation in 1982. Its ... quality diagnostic allergy and immunology testing ...

Medicine Products:

Histopathology Reference Laboratory PhenoPath Laboratories LabCorp Dermatology, Allergy and Clinical Immunology (DACI) Reference Laboratory

( derectile dysfunction. Duloxetine is...)In New Study, Duloxetine Reduced Non-specific Pain and Emotional,Symptoms Associated with Depression,Health